Back
Outlook Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
OTLK
Sponsored
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Sell
25
OTLK
Outlook Therapeutics
Last Price:
7.52
Seasonality Move:
19.48%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Outlook Therapeutics Price Quote
$7.52
-0.06 (-0.79%)
(Updated: May 13, 2024 at 6:55 PM ET)
Outlook Therapeutics Key Stats
Sell
25
Outlook Therapeutics (OTLK)
is a Sell
Day range:
$7.50 - $8.13
52-week range:
$4.00 - $40.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
12.03
P/B ratio:
0%
Volume:
392.5K
Avg. volume:
350.3K
1-year change:
-67.88%
Market cap:
$163.6M
Revenue:
$0
EPS:
$-4
How Much Does Outlook Therapeutics Make?
Data Unavailable
Is Outlook Therapeutics Growing As A Company?
Data Unavailable
Outlook Therapeutics Stock Price Performance
-
Did Outlook Therapeutics Stock Go Up Last Month?
Outlook Therapeutics share price went down by -15.68% last month -
Did OTLK's Share Price Rise Over The Last Year?
OTLK share price fell by -67.88% over the past 1 year
What Is Outlook Therapeutics 52-Week High & Low?
-
What Is Outlook Therapeutics’s 52-Week High Share Price?
Outlook Therapeutics has traded as high as $40.60 over the past 52 weeks -
What Is Outlook Therapeutics’s 52-Week Low Share Price?
Outlook Therapeutics has traded as low as $4.00 over the past 52 weeks
Outlook Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Outlook Therapeutics?
-
How Much Debt Does Outlook Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Outlook Therapeutics Have?
Cash and short term investments quarterly total is $10.4M -
What Is Outlook Therapeutics’s Book Value Per Share?
Book value per share is -1.87
Is Outlook Therapeutics Cash Flow Positive?
-
What Is OTLK Cash Flow From Operations?
Cash flow from operations (TTM) is -$47.1M -
What Is Outlook Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.1M -
What Is Outlook Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Outlook Therapeutics Return On Invested Capital
Data Unavailable
Outlook Therapeutics Earnings Date & Stock Price
-
What Is Outlook Therapeutics's Stock Price Today?
A single share of OTLK can be purchased today for 7.58 -
What Is Outlook Therapeutics’s Stock Symbol?
Outlook Therapeutics trades on the nasdaq under the ticker symbol: OTLK -
When Is Outlook Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Outlook Therapeutics is scheduled on May 16, 2024 -
When Is OTLK's next ex-dividend date?
Outlook Therapeutics's next ex-dividend date is May 15, 2020 -
How To Buy Outlook Therapeutics Stock?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Outlook Therapeutics Competitors
-
Who Are Outlook Therapeutics's Competitors?
Below is a list of companies who compete with Outlook Therapeutics or are related in some way:
Outlook Therapeutics Dividend Yield
Data Unavailable
Outlook Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 27.06% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 39.86 |
Upside from Last Price: | 425.82% |